Stocks and Investing
Stocks and Investing
Thu, October 4, 2012
[ 08:00 AM ] - Market Wire
[ 07:50 AM ] - Market Wire
[ 07:41 AM ] - WOPRAI
[ 07:41 AM ] - WOPRAI
[ 07:41 AM ] - WOPRAI
[ 07:40 AM ] - WOPRAI
[ 07:40 AM ] - WOPRAI
[ 07:40 AM ] - WOPRAI
[ 07:40 AM ] - WOPRAI
[ 07:40 AM ] - WOPRAI
[ 05:40 AM ] - WOPRAI
[ 04:00 AM ] - Market Wire
[ 04:00 AM ] - Market Wire
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jasper Hellweg Initiated (VRTX) at Strong Buy on, Oct 4th, 2012
Jasper Hellweg of Argus Research, Initiated "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy on, Oct 4th, 2012.
Jasper has made no other calls on VRTX in the last 4 months.
There is 1 other peer that has a rating on VRTX. Out of the 1 peers that are also analyzing VRTX, 0 agree with Jasper's Rating of Hold.
This is the rating of the analyst that currently disagrees with Jasper
- Ying Huang of "B of A Securities" Maintained at Strong Buy with Decreased Target to $66 on, Tuesday, July 31st, 2012